Noteworthy, the last two examples represent the GPCR family, and keeping in mind that there are >500 of these receptors encoded in the human genome, the enormous potential to exploit GPCR-mediated targeting of ovarian cancer is assessed in the next section. This evidence concerns the gene LPAR3 and ovarian cancer.